← SynDRA
VILANTEROL
SynDRA canonical compound SYN0022906 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Primary target(s) | ADRB2 |
| Mechanism of action | adrenergic receptor agonist |
| Indication | chronic obstructive pulmonary disease (COPD) |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
- adrenergic receptor agonist
- ADRB2 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SLC6A4
- SLC6A3
- ADRA1A
- SCN5A
- DRD1
- NR3C1
- HTR2B
- HTR2C
- HTR3A
- MAOA
- MC3R
- MLNR
- NR1I2
- OPRM1
- OPRD1
- HTR1A
- PDE3A
- PDE4D
- PGR
- PPARG
- PTGS2
- SLC29A1
- SLC6A2
- HTR2A
- ABCB11
- HRH3
- ADORA1
- ADORA2A
- ADORA3
- ADRA2A
- ADRA2B
- ADRA2C
- AGTR1
- AVPR1A
- CCKAR
- CHRM1
- CHRM2
- CHRM3
- CHRNA4
- CNR1
Drug classes
- Adrenergic beta2-Agonists
- beta2-Adrenergic Agonist
ATC classes
Cross-references
Synonyms
- ANORO ELLIPTA
- BREO ELLIPTA
- TRELEGY ELLIPTA
- GW642444X
- Breo Ellipta
- vilanterol trifenatate
- GW642444M
- GW-642444
- GW-642444X
- GW642444
- Fumagillinum
- Fumagilline
- Fumagilina
- Fumidil
- Fugillin
- UNII-7OW73204U1
- Amebacillin
- Fugilin
- CHEMBL32838
- Fumagillin DCH
- CHEBI:48635
- Fumagillina [DCIT]
- 7OW73204U1
- Fumagillinum [INN-Latin]
- Fumagilline [INN-French]
- Fumagilina [INN-Spanish]
- DSSTox_RID_79580
- DSSTox_CID_20736
- DSSTox_GSID_40736
- Fumagillin [INN:BAN:DCF]
- GW642444x
- UNII-028LZY775B
- GW-642444x
- CHEBI:75037
- 028LZY775B
- Vilanterol (GW642444
- GW 642444X)
- Vilanterol [USAN:INN]
Look up VILANTEROL in the interactive SynDRA portal →